Uterine Fibroids News and Research

Latest Uterine Fibroids News and Research

URMC research confirms possible use of mifepristone for painful fibroids

URMC research confirms possible use of mifepristone for painful fibroids

Philips introduces new innovative and cost-effective solutions for radiology at ECR 2011

Philips introduces new innovative and cost-effective solutions for radiology at ECR 2011

Uterine fibroid treatments greatly improve quality of life in women

Uterine fibroid treatments greatly improve quality of life in women

U.S. District Court rules in favor of Hologic in breast brachytherapy patent infringement lawsuit

U.S. District Court rules in favor of Hologic in breast brachytherapy patent infringement lawsuit

FDA approves Hologic's 3-D digital mammography system to diagnose breast cancer

FDA approves Hologic's 3-D digital mammography system to diagnose breast cancer

Hologic receives FDA approval for hydroxyprogesterone caproate injection

Hologic receives FDA approval for hydroxyprogesterone caproate injection

Miracle baby after radical new procedure for uterine fibroids

Miracle baby after radical new procedure for uterine fibroids

Uterine health is more relevant for fetus to achieve normal birth weight, full gestation

Uterine health is more relevant for fetus to achieve normal birth weight, full gestation

FDA approves Boston Scientific's Renegade HI-FLO Fathom Pre-Loaded System

FDA approves Boston Scientific's Renegade HI-FLO Fathom Pre-Loaded System

Watson predicts $4.2 billion in revenues from Global Generics and Global Brand businesses

Watson predicts $4.2 billion in revenues from Global Generics and Global Brand businesses

Hologic announces acquisition of Interlace Medical

Hologic announces acquisition of Interlace Medical

FDA approves Watson's novel oral contraceptive

FDA approves Watson's novel oral contraceptive

Halt Medical presents results of Halt Fibroid Study at NIH Global Fibroid Congress

Halt Medical presents results of Halt Fibroid Study at NIH Global Fibroid Congress

Repros prepares for dosing 3 mg cohort in low dose Proellex study in uterine fibroids and endometriosis

Repros prepares for dosing 3 mg cohort in low dose Proellex study in uterine fibroids and endometriosis

Watson, PregLem enter licensing agreement to develop, market Esmya in the U.S. and Canada

Watson, PregLem enter licensing agreement to develop, market Esmya in the U.S. and Canada

New robotic arm device for early to mid-stage osteoarthritis

New robotic arm device for early to mid-stage osteoarthritis

Elbit Imaging closes transaction with Enter

Elbit Imaging closes transaction with Enter

Neurocrine third quarter revenue increases from $0.7 million to $14.4 million

Neurocrine third quarter revenue increases from $0.7 million to $14.4 million

Halt Medical's Tulip RFVTA probe granted Canadian approval for treatment of uterine fibroids

Halt Medical's Tulip RFVTA probe granted Canadian approval for treatment of uterine fibroids

Researchers propose Nintendo Wii gaming to control gestational diabetes in women

Researchers propose Nintendo Wii gaming to control gestational diabetes in women